Sumeet Indulkar

Head of Business Development Ajanta | Ex Sun | IQVIA | Macleods | Glenmark

Role: Head of Business Development at Ajanta Pharma Ltd
Location: Mumbai, MH, IN
LinkedIn followers: 500 followers

Sales & Business DevelopmentView LinkedIn profile

About Sumeet Indulkar

Sumeet Indulkar is a seasoned pharmaceutical professional with over 18 years of…

Experience

Head of Business Development
Ajanta Pharma Ltd
May 2025 — Present · Mumbai, IN

Education

University of Mumbai
MBA - Pharma Management, Marketing and Management
2007 — 2008
The Wharton School
Executive education Program - Startups, Innovation & Business growth strategy
2019 — 2020

Skills

Pharmaceutics
Crm
Bioequivalence
Regulatory Affairs
Pharmacovigilance
Competitive Intelligence
Marketing Strategy
Budgeting
Strategy
Market Research
International Marketing
Budget Monitoring
Pharmaceutical Industry
Business Development
Oncology
Clinical Data Management
Planning Budgeting & Forecasting
Pharmaceutical Sales
Strategic Planning
Management
Corporate Strategy Formulation
Business Analysis
Market Analysis
Analysis
CRO
Competitive Analysis

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@ajantapharma.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Ajanta Pharma Ltd

Pharmaceutical Manufacturing · 10K employees · Founded 1973 · Ajanta Tower, 54-A, M Vasanji Road, Chakala, Andheri (E), IN

Ajanta Pharma Limited is a pharmaceutical company headquartered in Mumbai, India. It has strong presence in Branded Generic business in India & Emerging markets; and Generic business in USA. In India, company operates in selected therapeutic areas of Cardiology, Dermatology, Ophthalmology, and Pain management. Recently Ajanta also got into two new promising therapies of Nephrology and Gynaecology. Its brands hold leadership positions in sub-therapeutic areas they are present in. In Emerging Markets, company has presence in Africa, South East Asia, West Asia, and CIS on broader therapeutic segments such as antimalarial, gastro, antibiotics, cardiology, dermatology, pain management, etc. As on 30th Mar 2026, Ajanta has 49 ANDA approvals, out of which 49 are commercialised. It is awaiting US FDA approval for 19 ANDAs. Company plans to file 8-12 ANDAs every year. Company has state-of-the-art research facilities for formulation and API development located at Mumbai, India. R&D capabilities are evident from number of 1st to market products launched by the company providing patients most needed compliance and convenience. A dedicated and focused team of over 850 scientists work for R&D, which is growing continuously. Ajanta has 6 formulations manufacturing facilities located in India. Besides that, it also has an API manufacturing facility located at Waluj, India. Ajanta’s flagship formulation facilities at Paithan (Maharashtra, India) and Dahej (Gujarat, India) have been approved by US FDA. Ajanta continuously invests in enhancing the existing manufacturing facilities to meet current cGMP requirements and also construct new facilities to meet company’s growth requirements. Please visit https://ajantapharma.com/ for more information.

ajantapharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Sumeet Indulkar

Experience

Head of Business Development

Education

University of Mumbai

The Wharton School

Skills

Find verified contacts for anyone on LinkedIn